Quality of Life 1y and 2 y After VV-ECMO for COVID-19, Measured by the 36-item Short Form Health Survey
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19 Acute Respiratory Distress Syndrome
- Sponsor
- University Hospital, Ghent
- Enrollment
- 28
- Locations
- 1
- Primary Endpoint
- Quality of life 1y after ECMO insertion
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This study aims to investigate the quality of life and the outcome after veno-venous extracoporeal membrane oxygenation (ECMO) support fir severe acute respiratory syndrome (ARDS) in COVID-19 patients.
Detailed Description
The investigators follow our COVID-19 patients supported by ECMO, we make phone calls or real-life visits to pthe patients to score the quality of life, by using the SF-36. The SF-36 measures eight scales: physical functioning, role physical, bodily pain, general health, vitality , social functioning , role emotional , and mental health. The participants are contacted 3 months, 6months, 1year and 2 years after the ECMO support started for evaluation of the SF-36.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with PCR-confirmed COVID-19 infection AND
- •Acute Respiratory Distress Syndrome who require veno-venous ECMO therapy.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Quality of life 1y after ECMO insertion
Time Frame: 1 year
Result of SF-36 1 year after VV-ECMO insertion
Quality of life 2y after ECMO insertion
Time Frame: 2 years
Result of SF-36 2 years after VV-ECMO insertion
in-hospital mortality
Time Frame: mortality during hospitalisation, up to two years
Secondary Outcomes
- Duration of mechanical ventilation(2 years)
- death after hospital discharge(after discharge from the hospital upon 2 years after)
- LOS ICU(from the day of intensive care unit admission until the day of transfer to the ward, up to two years)
- Lung complications requiring surgical treatment(From the start of VV-ECMO support until weaning of VV-ECMO, up to two years)
- LOS hospital(from the day of hospital admission until the day that the participant is transferred to home, up to two years)
- Incidence of acute kidney injury(from the day of hospital admission until the day that the participant is transferred to home, up to two years)